Lyell Immunopharma, Inc (LYEL)
$1.57
Lyell Immunopharma, Inc (LYEL) Share Price Forecast
Currently 11 wall-street analysts regularly analyze the financials of Lyell Immunopharma, Inc on a frequent basis to provide recommendations along with target share price. 11 analysts offering 12-month price forecasts for Lyell Immunopharma, Inc (LYEL) have a share price target of $6.8. This median of share price forecast represents a 333.12% upside from the latest price of $1.57 as on 29.09.23.
Lyell Immunopharma, Inc (LYEL) Price vs Consensus Price Target
Price
Target Price
As per the chart shown above, analysts believe that the Lyell Immunopharma, Inc (LYEL) share price will touch around $6.8 in next 12-months.
Lyell Immunopharma, Inc (LYEL) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Lyell Immunopharma, Inc's share price and its median forecast price. As on 29.09.23, the difference is -65.59%
Lyell Immunopharma, Inc (LYEL): Difference between Current Price & Median Forecasted Price
Difference in Percentage terms
Lyell Immunopharma, Inc (LYEL) Share Price : Analyst Recommendation
Based on 11 analysts tracking and researching Lyell Immunopharma, Inc (LYEL) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 5 | 5 | 5 |
| Outperform | 3 | 3 | 3 |
| Hold | 3 | 3 | 3 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
Lyell Immunopharma, Inc (LYEL) Share Price Technical Analysis
50 Day Moving Average v/s Current Share Price
Moving Average
Price
200 Day Moving Average v/s Current Share Price
Moving Average
Price
FAQs
The latest share price target for Lyell Immunopharma, Inc (LYEL) is $6.8, offered by 11 analysts offering 12-month price forecasts.
Lyell Immunopharma, Inc (LYEL) has a maximum of 3.33 upside potential, based on 11 analysts offering 12-month price forecasts.
Based on 11 analysts tracking and researching Lyell Immunopharma, Inc (LYEL), 72.73% have a buy recommendation. Remaining 27.27% have either sell or hold recommendations.
The latest share price of Lyell Immunopharma, Inc (LYEL) is $1.57 as of 29/09/2023.
8 of total 11 analysts offering stock ratings for Lyell Immunopharma, Inc LYEL have recommended buy rating.
₹0 US Stocks a/c Opening Fee